Patents by Inventor Qing Dallas-yang

Qing Dallas-yang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD FOR SCREENING DRUG-SACCHARIDE CONJUGATES
    Publication number: 20170254798
    Abstract: Methods for identifying drug-saccharide conjugates that bind the mannose receptor, C type 1, (MRC1) and may be taken up by cells expressing MRC1, and the use of such drug-saccharide conjugates for treatment of particular diseases are described. In particular, the methods for identifying insulin-saccharide conjugates that bind the MRC1 receptor and may be taken up by cells expressing the MRC1 and use of such conjugates for treatment of diabetes are described.
    Type: Application
    Filed: March 4, 2016
    Publication date: September 7, 2017
    Applicant: Merck Sharp & Dohme Corp.
    Inventors: Yingjun Mu, Ruojing Yang, Xinghai Li, Margaret Wu, Qing Dallas-yang, Yuli Chen, Ge Dai, Songnian Lin, David E. Kelley, Mark Erion
  • METHOD FOR SCREENING DRUG-SACCHARIDE CONJUGATES
    Publication number: 20170248580
    Abstract: Methods for identifying drug-saccharide conjugates that bind the mannose receptor, C type 1, (MRC1) and may be taken up by cells expressing MRC1, and the use of such drug-saccharide conjugates for treatment of particular diseases are described. In particular, the methods for identifying insulin-saccharide conjugates that bind the MRC1 receptor and may be taken up by cells expressing the MRC1 and use of such conjugates for treatment of diabetes are described.
    Type: Application
    Filed: May 15, 2017
    Publication date: August 31, 2017
    Applicant: Merck Sharp & Dohme Corp.
    Inventors: Yingjun Mu, Ruojing Yang, Xinghai Li, Margaret Wu, Qing Dallas-yang, Yuli Chen, Ge Dai, Songnian Lin, David E. Kelley, Mark Erion